Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,604.50
Bid: 1,604.00
Ask: 1,604.50
Change: -5.50 (-0.34%)
Spread: 0.50 (0.031%)
Open: 1,611.50
High: 1,615.50
Low: 1,599.50
Prev. Close: 1,610.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: UK Stocks Set To Open Flat To Slightly Lower

Wed, 30th Apr 2014 06:45

LONDON (Alliance News) - UK equities are set to open flat to slightly lower Wednesday, following some strong gains posted on Tuesday, as investors take their positions ahead of important macro economic releases from Europe and the US.

Meanwhile, market participants in London face another day of transport disruptions as the 48-hour tube strike by members of the Rail, Maritime and Transport (RMT) union continues.

Global stocks closed significantly higher on Tuesday, with the FTSE 100 closing at its highest level for seven weeks; the CAC 40 in Paris closing at its highest level since 2008; and the DAX 30 in Frankfurt and the DJIA and S&P 500 on Wall Street all ending the day at multi-day highs.

"Exactly where the optimism for that extended rally stemmed from was not immediately obvious," says Rabobank analyst Michael Every.

The gains came despite economic data from around the world largely falling short of expectations, and the US and EU imposing additional sanctions on Russian interests as part of the ongoing Ukraine crisis.

"Either of these would have weighed heavily on sentiment and left markets in the red a few weeks ago, but that is not the case at the moment," says Craig Erlam, market analyst at Alpari. "Investors are instead being buoyed by the daily reports of mergers and acquisitions, particularly in healthcare stocks, and first quarter earnings, which haven?t been as bad as first feared despite the poor weather in the first couple of months."

However, positivity is set to wane Wednesday. The FTSE 100, which closed at 6,769.91 on Tuesday, is expected to open flat to slightly lower. Alpari indicates the blue-chip index to open down just 1 point, while CMC Markets and IG expect it to open even lower, down 18 points at approximately 6,751 points.

This follows a mixed trading session in Asia, where "the major indices are all treading water after a fairly quiet session that included one of the most uneventful policy decisions from the Bank of Japan you?re ever likely to see," says Erlam.

The BoJ left its monetary policy unchanged, as had been widely expected by economists. Members voted unanimously to increase the monetary base by between JPY60 trillion and JPY70 trillion a year.

Ahead of the UK equity market open, the Nikkei in Tokyo is up 0.3%, the Shanghai Composite index is up 0.7%, while the Hang Seng is down over 1%.

"Focus this morning will be on euro area preliminary HICP (harmonised index of consumer prices) - seen as a key gauge in determining if the European Central Bank will provide more monetary stimulus next week," says Carl Paraskevas, senior international macroeconomist at Lloyds Bank.

Consensus estimates are for the reading to rise to 0.8% in April, up from the 0.5% seen in March. However, weaker-than-expected April CPI data from Germany increases may weigh on the number.

The ADP employment change figure for April, released at 1215 GMT, will be used for directional guidance for Friday's non-farm payrolls. Consensus expectations are for the ADP report is to improve to 210,000, up from 191,000 new jobs added in March.

Shortly after, the preliminary reading of US first quarter GDP is published at 1230 GMT. This is "widely expected to be disappointing after the deep-freeze US winter," says Michael Hewson, chief market analyst at CMC Markets. An annualised reading of 1.2% is expected, down from 2.6% in the fourth quarter of last year.

Meanwhile, after the UK equity market close, the US Federal Open Market Committee publishes its latest interest rate and monetary policy decisions upon the conclusion of its latest policy meeting at 1800 GMT.

Although significant, "for the first time in a very long time markets aren?t expected to be hanging on to every single nuance coming from the culmination of a Federal Reserve FOMC rate decision," says Hewson.

Expectations are for the FOMC to taper its monthly asset purchases by another USD10 billion. There is no press conference scheduled for after the announcement.

Also in the data calendar Wednesday, French consumer spending and producer prices data are released at 0645 GMT, ahead of German and Italian unemployment information at 0755 GMT and 0800 GMT, respectively. The preliminary reading of consumer price inflation for Italy for April is scheduled at 0900 GMT.

In the US, the Mortgage Bankers Association releases its MBA mortgages applications data at 1100 GMT. The Chicago purchasing managers' index is released at 1345 GMT.

In corporate news, FTSE 100-listed CSR has published first quarter results ahead of the UK equity market open Wednesday. Blue-chips Standard Life, Next, and Tullow Oil have been joined by mid-caps International Personal Finance, Ladbrokes, SVG Capital, Ultra Electronics, Playtech, and Greene King, amongst others, in releasing trading updates.

FTSE 250-listed Home Retail Group has released full-year results.

Pharmaceutical giant GlaxoSmithKline is due to publish its first quarter results at 1300 GMT.

By James Kemp; jameskemp@alliancenews.com; @jamespkemp

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.